ArticlePloS one2012
A novel anticancer therapy that simultaneously targets aberrant p53 and Notch activities in tumors.
Yuting Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticlePloS one2012
Yuting Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.